Older patients who are receiving a calcium-channel blocker at increased risk of hospital admission for hypotension or shock if they take erythromycin or clarithromycin concomitantly, says study.
Sanofi-aventis and Health Canada are notifying healthcare professionals about the potential for serious liver injury with Multaq (dronedarone), including rare cases of hepatic failure.